X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (117) 117
index medicus (85) 85
oncology (74) 74
female (69) 69
male (61) 61
middle aged (56) 56
aged (54) 54
adult (44) 44
quality of life (44) 44
cancer (43) 43
chemotherapy (36) 36
clinical trials (30) 30
aged, 80 and over (26) 26
medicine, general & internal (26) 26
treatment outcome (24) 24
care and treatment (23) 23
research (23) 23
quality-of-life (22) 22
prognosis (21) 21
australia (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
surveys and questionnaires (18) 18
analysis (16) 16
breast cancer (16) 16
clinical-trials (16) 16
randomized controlled trials as topic (16) 16
survival (16) 16
medicine & public health (15) 15
patients (15) 15
prostate cancer (15) 15
survival rate (15) 15
decision-making (14) 14
health care sciences & services (14) 14
hematology, oncology and palliative medicine (14) 14
neoplasm staging (14) 14
therapy (14) 14
adolescent (13) 13
breast neoplasms - drug therapy (13) 13
metastasis (13) 13
survival analysis (13) 13
breast neoplasms - pathology (12) 12
decision making (12) 12
follow-up studies (12) 12
adjuvant chemotherapy (11) 11
health policy & services (11) 11
oncology, experimental (11) 11
antineoplastic agents - therapeutic use (10) 10
medical research (10) 10
patient outcomes (10) 10
patient satisfaction (10) 10
patient-reported outcomes (10) 10
radiotherapy (10) 10
breast neoplasms - surgery (9) 9
cancer patients (9) 9
docetaxel (9) 9
drug therapy (9) 9
health aspects (9) 9
lung neoplasms - drug therapy (9) 9
studies (9) 9
time factors (9) 9
cancer therapies (8) 8
carcinoma, non-small-cell lung - drug therapy (8) 8
disease-free survival (8) 8
genetics & heredity (8) 8
neoplasms - psychology (8) 8
ovarian cancer (8) 8
palliative care (8) 8
preferences (8) 8
prostate-specific antigen - blood (8) 8
public health (8) 8
public, environmental & occupational health (8) 8
quality of life research (8) 8
surgery (8) 8
tumors (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
breast neoplasms - mortality (7) 7
care (7) 7
chemotherapy, adjuvant (7) 7
cisplatin (7) 7
double-blind (7) 7
drug administration schedule (7) 7
health-related quality of life (7) 7
internal medicine (7) 7
lung neoplasms - mortality (7) 7
management (7) 7
medicine (7) 7
neoplasms - therapy (7) 7
obstetrics & gynecology (7) 7
phase-iii trial (7) 7
randomized-trial (7) 7
risk factors (7) 7
usage (7) 7
breast neoplasms - psychology (6) 6
breast-cancer (6) 6
carcinoma (6) 6
cells (6) 6
drug resistance, neoplasm (6) 6
health policy (6) 6
health status (6) 6
life expectancy (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 2013, Volume 158, Issue 2, p. JC9
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 2013, Volume 158, Issue 2, p. JC2
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e14576 - e14576
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e23017 - e23017
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e22139 - e22139
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2019, Volume 381, Issue 15, pp. 1493 - 1495
To the Editor: Multiple new trials, including the ENZAMET (Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer) trial... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. TPS331 - TPS331
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 06/2016, Volume 204, Issue 11, pp. 403 - 405
Treatment related adverse effects and financial burden needs to be evaluated while valuing benefits of new anticancer drugs. Better chances of survival and... 
Neoplasms | Antineoplastic Agents - therapeutic use | Australia | Cost-Benefit Analysis | Drug Industry | Humans | Antineoplastic Agents - economics | MEDICINE, GENERAL & INTERNAL | Antimitotic agents | Symptomatology | Care and treatment | Analysis | Dosage and administration | Antineoplastic agents | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 4547 - 4547
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 2_suppl, pp. 487 - 487
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.